A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Clinical trial NCT05328908 · TERMINATED

Trial details

NCT number: NCT05328908
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2022-04-28
Primary completion: 2025-07-14
Enrollment: 770

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.